Other languages DMK Pharmaceuticals Corporation

Equities

DMKPQ

US00547W3079

Delayed OTC Markets Other stock markets 09:30:03 2024-06-03 am EDT			5-day change	1st Jan Change
0.0293 ^USD	-2.33%		-2.33%	-95.82%

May. 30	First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation	CI
May. 08	Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation	May. 30
Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation	May. 08
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	Apr. 11
North American Morning Briefing : Focus Turns to -2-	Apr. 04
Bidding Procedure Approved for DMK Pharmaceuticals Corporation	Apr. 04
Motion for Asset Sale Filed by DMK Pharmaceuticals Corporation	Mar. 21
DMK Pharmaceuticals Corporation(NasdaqCM:DMK) dropped from S&P TMI Index	Feb. 07
Motion for Joint Administration Approved for DMK Pharmaceuticals Corporation	Feb. 06
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) dropped from NASDAQ Composite Index	Feb. 05
DMK Pharmaceuticals Commences Restructuring Proceeding	Feb. 02
Motion for Joint Administration Filed by DMK Pharmaceuticals Corporation	Feb. 02
DMK Pharmaceuticals Corporation Filed for Bankruptcy	Feb. 02
DMK Pharmaceuticals Corporation Announces Board Appointments	Jan. 31
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI	Dec. 21
Maxim Starts DMK Pharmaceuticals With Buy Rating, $1.50 Price Target	Dec. 07
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update	Nov. 28
DMK Pharmaceuticals Corporation Regains Full Rights from US WorldMeds for SYMJEPI	Nov. 28
DMK Pharmaceuticals Corporation(OTCPK:DMKP.Q) added to NASDAQ Composite Index	Nov. 20
Adamis Pharmaceuticals Corporation(NasdaqCM:ADMP) dropped from NASDAQ Composite Index	Nov. 20
DMK Pharmaceuticals: Q3 Earnings Snapshot	Nov. 14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages DMK Pharmaceuticals Corporation

Equities

DMKPQ

US00547W3079

Other languages

Filters